Financials

Discussions Technicals Seasonals

4186 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to TAIWAN ADVANCE BIO-PHARM INC operating, investing, and financing activities

4186 free cash flow for H2 24 is 11.78 M TWD. For 2024, 4186 free cash flow was 11.27 M TWD and operating cash flow was 15.23 M TWD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—